----

|                                                                                                                                         |
|-----------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                         |  |  |  |  |  |  |  |  |  |  |
|                                                                                                                                    | As  Reported |   | Pro Forma Adjustments |   | As Adjusted |
| ASSETS                                                                                                                                  |   |   |   |   |   |
| Cash and cash equivalents                                                                                                               | $ | 459,242 |  |   | — |  | (1)  | $ | 459,242 |  |
| Restricted cash and equivalents                                                                                                         | 102,192 |  |   |   |   | 102,192 |  |
| Short-term investments                                                                                                                  | 4,035 |  |   |   |   | 4,035 |  |
| Accounts receivable, net                                                                                                                | 1,953,422 |  |   |   |   | 1,953,422 |  |
| Inventories                                                                                                                             | 104,236 |  |   |   |   | 104,236 |  |
| Other receivables                                                                                                                       | 489,581 |  |   |   |   | 489,581 |  |
| Income tax receivable                                                                                                                   | 42,650 |  |   |   |   | 42,650 |  |
| Prepaid and other current assets                                                                                                        | 64,770 |  |   |   |   | 64,770 |  |
| Current assets held for sale, net                                                                                                       | 6,004,948 |  |   | (6,004,948 | ) | (2)  | — |  |
| Total current assets                                                                                                                    | 9,225,076 |  |   |   |   | 3,220,128 |  |
| Property and equipment, net of accumulated depreciation of $3,538,992 and $3,524,098                                                    | 3,392,266 |  |   |   |   | 3,392,266 |  |
| Operating lease right-of-use assets                                                                                                     | 2,736,536 |  |   |   |   | 2,736,536 |  |
| Intangible assets, net of accumulated amortization of $82,265 and $80,566                                                               | 118,324 |  |   |   |   | 118,324 |  |
| Equity method and other investments                                                                                                     | 226,309 |  |   |   |   | 226,309 |  |
| Long-term investments                                                                                                                   | 34,414 |  |   |   |   | 34,414 |  |
| Other long-term assets                                                                                                                  | 73,651 |  |   |   |   | 73,651 |  |
| Goodwill                                                                                                                                | 6,799,368 |  |   |   |   | 6,799,368 |  |
|                                                                                                                                    | $ | 22,605,944 |  |   |   |   | $ | 16,600,996 |  |
| LIABILITIES AND EQUITY                                                                                                                  |   |  |   |   |   |   |
| Accounts payable                                                                                                                        | $ | 365,192 |  |   |   |   | $ | 365,192 |  |
| Other liabilities                                                                                                                       | 572,944 |  |   | 40,000 |  | (3)  | 612,944 |  |
| Accrued compensation and benefits                                                                                                       | 495,327 |  |   |   |   | 495,327 |  |
| Current portion of operating leases liabilities                                                                                         | 367,413 |  |   |   |   | 367,413 |  |
| Current portion of long-term debt                                                                                                       | 4,676,691 |  |   | (3,848,176 | ) | (4)  | 828,515 |  |
| Current liabilities held for sale                                                                                                       | 1,753,310 |  |   | (1,753,310 | ) | (2)  | — |  |
| Total current liabilities                                                                                                               | 8,230,877 |  |   |   |   | 2,669,391 |  |
| Long-term operating leases liabilities                                                                                                  | 2,625,776 |  |   |   |   | 2,625,776 |  |
| Long-term debt                                                                                                                          | 5,787,013 |  |   | (604,050 | ) | (4)  | 5,182,963 |  |
| Other long-term liabilities                                                                                                             | 143,756 |  |   |   |   | 143,756 |  |
| Deferred income taxes                                                                                                                   | 588,805 |  |   |   |   | 588,805 |  |
| Total liabilities                                                                                                                       | 17,376,227 |  |   |   |   | 11,210,691 |  |
| Commitments and contingencies:                                                                                                          |   |   |   |   |   |
| Noncontrolling interests subject to put provisions                                                                                      | 1,143,044 |  |   |   |   | 1,143,044 |  |
| Equity:                                                                                                                                 |   |   |   |   |   |
| Preferred stock ($0.001 par value, 5,000,000 shares authorized; none issued)                                                            | — |  |   |   |   | — |  |
| Common stock ($0.001 par value, 450,000,000 shares authorized; 166,387,307 and 182,462,278 shares issued and outstanding, respectively) | 166 |  |   |   |   | 166 |  |
| Additional paid-in capital                                                                                                              | 990,380 |  |   |   |   | 990,380 |  |
| Retained earnings                                                                                                                       | 2,932,359 |  |   | 177,734 |  | (5)  | 3,110,093 |  |
| Accumulated other comprehensive loss                                                                                                    | (47,551 | ) |   |   |   | (47,551 | ) |
| Total DaVita Inc. shareholders' equity                                                                                                  | 3,875,354 |  |   |   |   | 4,053,088 |  |
| Noncontrolling interests not subject to put provisions                                                                                  | 211,319 |  |   | (17,146 | ) | (6)  | 194,173 |  |
| Total equity                                                                                                                            | 4,086,673 |  |   |   |   | 4,247,261 |  |
|                                                                                                                                    | $ | 22,605,944 |  |   |   |   | $ | 16,600,996 |  |

----

|                                                           |
|-----------------------------------------------------------|
|                                                           |  |  |  |  |  |  |  |  |  |  |
|                                                           | As  Reported |   | Pro Forma Adjustments |  | As Adjusted |
| Dialysis and related lab patient service revenues         | $ | 2,635,152 |  |   |   |   | $ | 2,635,152 |  |
| Provision for uncollectible accounts                      | (5,463 | ) |   |   |   | (5,463 | ) |
| Net dialysis and related lab patient service revenues     | 2,629,689 |  |   |   |   | 2,629,689 |  |
| Other revenues                                            | 113,423 |  |   |   |   | 113,423 |  |
| Total revenues                                            | 2,743,112 |  |   |   |   | 2,743,112 |  |
| Operating expenses and charges:                           |   |  |   |   |   |   |
| Patient care costs                                        | 1,964,935 |  |   |   |   | 1,964,935 |  |
| General and administrative                                | 250,813 |  |   |   |   | 250,813 |  |
| Depreciation and amortization                             | 148,528 |  |   |   |   | 148,528 |  |
| Equity investment income                                  | (2,708 | ) |   |   |   | (2,708 | ) |
| Goodwill impairment charges                               | 41,037 |  |   |   |   | 41,037 |  |
| Total operating expenses and charges                      | 2,402,605 |  |   |   |   | 2,402,605 |  |
| Operating income                                          | 340,507 |  |   |   | (7)  | 340,507 |  |
| Debt expense                                              | (131,519 | ) |   | 56,076 |  | (8)  | (75,443 | ) |
| Other income, net                                         | 6,940 |  |   |   |   | 6,940 |  |
| Income from continuing operations before income taxes     | 215,928 |  |   |   |   | 272,004 |  |
| Income tax expense                                        | 56,746 |  |   | 14,433 |  | (8)  | 71,179 |  |
| Net income from continuing operations                     | 159,182 |  |   |   |   | 200,825 |  |
| Net income from discontinued operations, net of tax       | 30,305 |  |   | (30,305 | ) | (9)  | — |  |
| Net income                                                | 189,487 |  |   |   |   | 200,825 |  |
| Less: Net income attributable to noncontrolling interests | (40,198 | ) |   | 1,270 |  | (10)  | (38,928 | ) |
| Net income attributable to DaVita Inc.                    | $ | 149,289 |  |   |   |   | $ | 161,897 |  |
| Earnings per share attributable to DaVita Inc.:           |    |   |   |   |   |
| Basic net income from continuing operations per share     | $ | 0.72 |  |   |   |   | $ | 0.97 |  |
| Basic net income per share                                | $ | 0.90 |  |   |   |   | $ | 0.97 |  |
| Diluted net income from continuing operations per share   | $ | 0.72 |  |   |   |   | $ | 0.97 |  |
| Diluted net income per share                              | $ | 0.90 |  |   |   |   | $ | 0.97 |  |
| Weighted average shares for earnings per share:           |   |  |   |   |   |   |
| Basic                                                     | 166,387,958 |  |   |   |   | 166,387,958 |  |
| Diluted                                                   | 166,780,657 |  |   |   |   | 166,780,657 |  |
| Amounts attributable to DaVita Inc.:                      |   |   |   |   |   |
| Net income from continuing operations                     | $ | 120,254 |  |   | 41,643 |  | (8)  | $ | 161,897 |  |
| Net income from discontinued operations                   | 29,035 |  |   | (29,035 | ) | (11)  | — |  |
| Net income attributable to DaVita Inc.                    | $ | 149,289 |  |   |   |   | $ | 161,897 |  |

----

|                                                           |
|-----------------------------------------------------------|
|                                                           |  |  |  |  |  |  |  |  |  |  |
|                                                           | As  Reported |   | Pro Forma Adjustments |  | As Adjusted |
| Dialysis and related lab patient service revenues         | $ | 10,709,981 |  |   |   |   | $ | 10,709,981 |  |
| Provision for uncollectible accounts                      | (49,587 | ) |   |   |   | (49,587 | ) |
| Net dialysis and related lab patient service revenues     | 10,660,394 |  |   |   |   | 10,660,394 |  |
| Other revenues                                            | 744,457 |  |   |   |   | 744,457 |  |
| Total revenues                                            | 11,404,851 |  |   |   |   | 11,404,851 |  |
| Operating expenses and charges:                           |   |  |   |   |   |   |
| Patient care costs and other costs                        | 8,195,513 |  |   |   |   | 8,195,513 |  |
| General and administrative                                | 1,135,454 |  |   |   |   | 1,135,454 |  |
| Depreciation and amortization                             | 591,035 |  |   |   |   | 591,035 |  |
| Provision for uncollectible accounts                      | (7,300 | ) |   |   |   | (7,300 | ) |
| Equity investment income                                  | 4,484 |  |   |   |   | 4,484 |  |
| Investment and other asset impairments                    | 17,338 |  |   |   |   | 17,338 |  |
| Goodwill impairment charges                               | 3,106 |  |   |   |   | 3,106 |  |
| Gain on changes in ownership interest, net                | (60,603 | ) |   |   |   | (60,603 | ) |
| Total operating expenses and charges                      | 9,879,027 |  |   |   |   | 9,879,027 |  |
| Operating income                                          | 1,525,824 |  |   |   | (7)  | 1,525,824 |  |
| Debt expense                                              | (487,435 | ) |   | 204,971 |  | (8)  | (282,464 | ) |
| Other income, net                                         | 10,089 |  |   |   |   | 10,089 |  |
| Income from continuing operations before income taxes     | 1,048,478 |  |   |   |   | 1,253,449 |  |
| Income tax expense                                        | 258,400 |  |   | 52,760 |  | (8)  | 311,160 |  |
| Net income from continuing operations                     | 790,078 |  |   |   |   | 942,289 |  |
| Net loss from discontinued operations, net of tax         | (457,038 | ) |   | 457,038 |  | (9)  | — |  |
| Net income                                                | 333,040 |  |   |   |   | 942,289 |  |
| Less: Net income attributable to noncontrolling interests | (173,646 | ) |   | 7,889 |  | (10)  | (165,757 | ) |
| Net income attributable to DaVita Inc.                    | $ | 159,394 |  |   |   |   | $ | 776,532 |  |
| Earnings per share attributable to DaVita Inc.:           |   |  |   |   |   |   |
| Basic net income from continuing operations per share     | $ | 3.66 |  |   |   |   | $ | 4.55 |  |
| Basic net income per share                                | $ | 0.93 |  |   |   |   | $ | 4.55 |  |
| Diluted net income from continuing operations per share   | $ | 3.62 |  |   |   |   | $ | 4.51 |  |
| Diluted net income per share                              | $ | 0.92 |  |   |   |   | $ | 4.51 |  |
| Weighted average shares for earnings per share:           |   |  |   |   |   |   |
| Basic                                                     | 170,785,999 |  |   |   |   | 170,785,999 |  |
| Diluted                                                   | 172,364,581 |  |   |   |   | 172,364,581 |  |
| Amounts attributable to DaVita Inc.:                      |   |   |   |   |   |
| Net income from continuing operations                     | $ | 624,321 |  |   | 152,211 |  | (8)  | $ | 776,532 |  |
| Net loss from discontinued operations                     | (464,927 | ) |   | 464,927 |  | (11)  | — |  |
| Net income attributable to DaVita Inc.                    | $ | 159,394 |  |   |   |   | $ | 776,532 |  |

----

|    |                                                                                                                                                                                                                                                                                                                                          |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1. | To adjust cash and cash equivalents for the receipt of approximately $4,465 million in preliminary net cash proceeds from the sale of DMG, reduced by approximately $4,465 million preliminary net cash proceeds used to pay down a portion of the Company's senior secured term debt, as further described in footnote 4 below. |

|    |                                                                                                                   |
|----|-------------------------------------------------------------------------------------------------------------------|
| 2. | Reflects the sale of the DMG business, which was previously classified as a discontinued operation held for sale. |

|    |                                                                                                                                    |
|----|------------------------------------------------------------------------------------------------------------------------------------|
| 3. | Reflects an accrual for estimated transaction costs and other net obligations associated with the transaction not paid at closing. |

|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4. | Reflects pro-rata partial principal prepayments of $583 million on Term Loan A, $892 million of Term Loan A-2, and $2,990 million of Term Loan B under the Company’s senior secured credit facilities using preliminary net cash proceeds from the sale of DMG, as well as a write-down of debt discount and deferred financing costs classified within long-term debt of $13 million. The terms of the Company's senior secured credit agreement as amended require that net cash proceeds from the sale in excess of $750 million be used to prepay debt outstanding under the Company's credit facilities. The Company intends to use all of the net cash proceeds from the sale (not only the amount in excess of $750 million) to prepay debt outstanding under its credit facilities at or soon after the closing of the sale. |

|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 5. | This amount represents the difference between (i) preliminary net cash proceeds received on the June 19, 2019 closing of the DMG sale, net of estimated remaining transaction costs and other obligations not paid at closing, and (ii) the sum of net assets classified as held for sale related to the DMG business as of March 31, 2019 and debt discount and deferred financing costs written down of $13 million (see footnote 4 above), that difference then increased by the elimination of noncontrolling interests attributable to DMG (see footnote 6 below). |

|    |                                                                           |
|----|---------------------------------------------------------------------------|
| 6. | Reflects the elimination of noncontrolling interests attributable to DMG. |

|    |                                                                                                                                                                                                                                                   |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 7. | The gain directly attributable to the sale of the DMG operations classified as discontinued operations does not have an impact on the Company’s operating income as presented on the unaudited pro forma consolidated statements of income. |

|    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 8. | To reflect the reduction of debt expense (including interest expense and amortization of debt discount and deferred financing costs) resulting from the pro forma prepayment in full of $775 million on Term Loan A, $3,378 million on Term Loan B, and $300 million on the revolving line of credit under the Company’s senior secured credit facilities, and related increase in income tax expense, based on the preliminary net cash proceeds from the June 19, 2019 sale of DMG described in footnote 1 above as if these debt principal payments were made immediately prior to January |

----

|    |                                                                              |
|----|------------------------------------------------------------------------------|
| 9. | To eliminate net income (loss) from DMG discontinued operations, net of tax. |

|     |                                                                                  |
|-----|----------------------------------------------------------------------------------|
| 10. | To eliminate net income attributable to noncontrolling interests related to DMG. |

|     |                                                                                         |
|-----|-----------------------------------------------------------------------------------------|
| 11. | To eliminate net income (loss) from discontinued operations attributable to DaVita Inc. |